Theracryf Plc – LSE:TCF.L
Theracryf stock price today
Theracryf stock price monthly change
Theracryf stock price quarterly change
Theracryf key metrics
Market Cap | 2.06M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTheracryf stock price history
Theracryf stock forecast
Theracryf financial statements
| 2024 | 396K | -3.13M | -792.17% |
|---|
| 2018 | 4260000 | 389K | 9.13% |
|---|---|---|---|
| 2024 | 3062000 | 721K | 23.55% |
| 2018 | -2.34M | -7K | 2.11M |
|---|---|---|---|
| 2020 | -2.57M | -1K | 4.67M |
| 2023 | -4.02M | 4.51M | 0 |
| 2024 | -2.99M | 0 | 0 |
Theracryf alternative data
| Dec 2024 | 9 |
|---|
Theracryf other data
-
What's the price of Theracryf stock today?
One share of Theracryf stock can currently be purchased for approximately $0.85.
-
When is Theracryf's next earnings date?
Unfortunately, Theracryf's (TCF.L) next earnings date is currently unknown.
-
Does Theracryf pay dividends?
No, Theracryf does not pay dividends.
-
How much money does Theracryf make?
Theracryf has a market capitalization of 2.06M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 104.12% to 396K US dollars.
-
What is Theracryf's stock symbol?
Theracryf Plc is traded on the LSE under the ticker symbol "TCF.L".
-
What is Theracryf's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Theracryf?
Shares of Theracryf can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Theracryf have?
As Dec 2024, Theracryf employs 9 workers.
-
When Theracryf went public?
Theracryf Plc is publicly traded company for more then 9 years since IPO on 21 Oct 2015.
-
What is Theracryf's official website?
The official website for Theracryf is theracryf.com.
-
How can i contact Theracryf?
Theracryf can be reached via phone at +44 1625 315090.
Theracryf company profile:
Theracryf Plc
theracryf.comLSE
9
Biotechnology
Healthcare
Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders. The company's lead product is SFX-01 that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase I clinical trials for the treatment of neurodevelopmental disorders and glioblastoma, as well as in preclinical stage for the treatment of rhabdomyosarcoma. In addition, it engages in the development of orexin 1 antagonist, which is in late preclinical stage targeting addiction and anxiety; and atypical dopamine transporter inhibitor (DAT), which is in late preclinical stage targeting fatigue and narcolepsy. The company was formerly known as Evgen Pharma plc and changed its name to Theracryf Plc in April 2024. Theracryf Plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.
Nether Alderley, SK10 4TG
:
ISIN: GB00BSVYN304
:
